Pharma Pulse 6/28/24: Pharmacy Closure Contributors, The Long-Term Consequences & more

Pharmacy Closure Contributors & Long-Term Consequences

In this part of his Pharmaceutical Executive video interview, Michael Abrams, Managing Partner, Numerof & Associates, identifies the main factors contributing to closures of pharmacies big and small and some potential long-term consequences for public health if they continue.

Public Health Matters: Generative AI and the Future of Pharmacy

Tune into this episode of “Public Health Matters” to hear Dr. Bolu Oladini’s unconventional journey within pharmacy, his passion for mental health, and how artificial intelligence is beginning to be integrated into health care and everyday life.

Goldman Sachs Deploys Its First Generative AI Tool Across the Firm

It started by centralizing all its proprietary AI technology on an internal platform, which CIO Marco Argenti said might have slowed it down at first but is now paying off.

Cell and Gene Therapy CRO Market Trends and Global Forecasts, 2035

The "Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering. The global cell and gene therapy CRO market is estimated to grow from $1.65 billion in 2024 to $3.51 billion by 2035, representing a CAGR of 7.1% during the forecast period 2024-2035.

@appliedclinicaltrials on Threads

In part 2 of this video interview, Diane Lacroix, vice president, clinical data management, eClinical Solutions highlights how artificial intelligence can help industry keep pace with the increasing complexity of data.

Have news you want us to share in Pharma Pulse? Reach out to Social

Media Editor Miranda Schmalfuhs